发明名称 Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
摘要 The use of autogenous bone graft is the current gold standard in the 1.5 million bone-grafting surgeries performed annually in the United States. Although this practice has resulted in high rates of fusion success, it is associated with increased operative time and blood loss, along with a significant degree of donor-site morbidity. Additionally, in certain settings such as revision cases, multilevel constructs, or in patients with medical comorbidities, autogenous bone graft may exist in limited quantity and quality. This significant need for a suitable alternative to autogenous bone graft has stimulated great interest in the exploration of bone graft substitutes and extenders.
申请公布号 US9072709(B2) 申请公布日期 2015.07.07
申请号 US201013379436 申请日期 2010.06.23
申请人 The Regents of the University of California;The United States of America Represented by The Department of Veterans Affairs 发明人 Murray Samuel S.;Murray Elsa;Wang Jeffrey;Behnam Keyvan
分类号 A61K38/10;A61K38/16;A61K38/18;A61K38/08 主分类号 A61K38/10
代理机构 McDermott Will & Emery LLP 代理人 McDermott Will & Emery LLP
主权项 1. An article of manufacture comprising a peptide comprising the amino acid sequence of SEQ ID NO: 11, or a fragment thereof, and at least one growth factor, wherein the peptide or fragment maintains an amount of growth factor in the proximity of the article greater than the presence of the amount of growth factor alone, and wherein said peptide or fragment enhances the degree or rate of osteogenesis in vertebrate cells.
地址 Oakland CA US